Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Hussain

Showing results (41-50 of 213) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the DetailsMaha Hussain, Catherine Tangen, Celestia Higano, et al.
The Journal of Urology|July 24, 2007
Bone directed therapies for prostate cancerDeborah A Bradley, Maha Hussain, Robert S Dipaola, et al.
Materia Socio-Medica|August 1, 2018
The Prevalence, the Fetal and Maternal Outcomes in Grand Multiparas WomenMaha Hussain Alhainiah, Hasan S O Abdulljabbar, Yasir Ahmad Bukhari
Cancer Causes & Control : CCC|October 25, 2003
Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States)Jill S Barnholtz-Sloan, Richard K Severson, Ulka Vaishampayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Molecular pathways: targeting ETS gene fusions in cancerFelix Y Feng, J Chad Brenner, Maha Hussain, et al.
The Oncologist|March 10, 2025
Response to pembrolizumab in advanced prostate cancer with predictive biomarkersNicole J Altomare, Yutai Li, Clayton Neill, et al.
Clinical Obstetrics and Gynecology|January 19, 2022
Vertical Transmission and Neonatal Outcomes Following Maternal SARS-CoV-2 Infection During PregnancyMargaret H Kyle, Maha Hussain, Victoria Saltz, et al.
BMC Cancer|January 26, 2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell lineDavid A Davis, Sarah H Sarkar, Maha Hussain, et al.
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate CancerMaha Hussain, Sylvestre Le Moulec, Claude Gimmi, et al.
Pageof 22

Showing results (41-50 of 213) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the DetailsMaha Hussain, Catherine Tangen, Celestia Higano, et al.
The Journal of Urology|July 24, 2007
Bone directed therapies for prostate cancerDeborah A Bradley, Maha Hussain, Robert S Dipaola, et al.
Materia Socio-Medica|August 1, 2018
The Prevalence, the Fetal and Maternal Outcomes in Grand Multiparas WomenMaha Hussain Alhainiah, Hasan S O Abdulljabbar, Yasir Ahmad Bukhari
Cancer Causes & Control : CCC|October 25, 2003
Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States)Jill S Barnholtz-Sloan, Richard K Severson, Ulka Vaishampayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Molecular pathways: targeting ETS gene fusions in cancerFelix Y Feng, J Chad Brenner, Maha Hussain, et al.
The Oncologist|March 10, 2025
Response to pembrolizumab in advanced prostate cancer with predictive biomarkersNicole J Altomare, Yutai Li, Clayton Neill, et al.
Clinical Obstetrics and Gynecology|January 19, 2022
Vertical Transmission and Neonatal Outcomes Following Maternal SARS-CoV-2 Infection During PregnancyMargaret H Kyle, Maha Hussain, Victoria Saltz, et al.
BMC Cancer|January 26, 2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell lineDavid A Davis, Sarah H Sarkar, Maha Hussain, et al.
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate CancerMaha Hussain, Sylvestre Le Moulec, Claude Gimmi, et al.
Pageof 22